Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 140

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 140
---
 in the Divestiture Agreement; or                          |

| • |     | (1) the Divestiture Agreement is terminated by either Kaken or Aadi, and (2) prior to such termination, at                                                                                                                                            
 the Special Meeting at which a vote is taken on the approval of the Divestiture Agreement, the Divestiture and the other transactions set forth in this proxy statement, Aadi stockholders have failed to approve the other transactions set forth in 
 this proxy statement.                                                                                                                                                                                                                                 |

The Divestiture Agreement also provides that Aadi, on the one hand, or Kaken, on the other hand, may specifically enforce the obligations under the Divestiture Agreement, except that a party may only cause the other party to complete the Divestiture if certain conditions are satisfied. Subject to limited exceptions, Aadi’s aggregate liability for monetary damages for breaches of the Divestiture Agreement is capped at the total amounts paid to Aadi as consideration under the Divestiture Agreement. Fees and Expenses Except in specified circumstances, whether or not the Divestiture is completed, Aadi, on the one hand, and Kaken, on the other hand, are each responsible for their respective fees and expenses incurred in connection with the Divestiture Agreement and the Divestiture. No Third-Party Beneficiaries The Divestiture Agreement is binding upon and inures solely to the benefit of each party thereto, and nothing in the Divestiture Agreement is intended to or will confer upon any other person any rights or remedies under the Divestiture Agreement. Amendment, Extension and Waiver Subject to applicable law and the provisions thereof, the Divestiture Agreement may be amended by the parties by execution of an instrument in writing signed on behalf of each party. Any party may, to the extent legally allowed and except as specified in the Divestiture Agreement, (1) extend the time for the performance of any of the obligations or other acts of the other parties, as applicable; (2) waive any inaccuracies in the representations and warranties made to such party in the Divestiture Agreement; and (3) subject to the requirements of applicable law, waive compliance with any of the agreements or conditions for the benefit of such party contained in the Divestiture Agreement. Any agreement by a party to any such extension or waiver will be valid only if set forth in an instrument in writing signed by such party. Any delay in exercising any right pursuant to the Divestiture Agreement will not constitute a waiver of such right. Governing